Skip to main content

Advertisement

Log in

Efficient and persistent transduction of exocrine and endocrine pancreas by adeno-associated virus type 8

  • Published:
Journal of Biomedical Science

Abstract

Efficient delivery of therapeutic proteins into the pancreas represents a major obstacle to gene therapy of pancreatic disorders. The current study compared the efficiency of recombinant lentivirus and adeno-associated virus (AAV) serotypes 1, 2, 5, 8 vectors delivered by intrapancreatic injection for gene transfer in vivo. Our results indicate that lentivirus and AAV 1, 2, 8 are capable of transducing pancreas with the order of efficiency AAV8 >>AAV1 > AAV2 ≥ lentivirus, whereas AAV5 was ineffective. AAV8 resulted in an efficient, persistent (150 days) and dose-dependent transduction in exocrine acinar cells and endocrine islet cells. Pancreatic ducts and blood vessels were also transduced. Extrapancreatic transduction was restricted to liver. Leukocyte infiltration was not observed in pancreas and blood glucose levels were not altered. Thus, AAV8 represents a safe and effective vehicle for therapeutic gene transfer to pancreas in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Raper S.E., DeMatteo R.P.: Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas. Pancreas 12:401–410, 1996

    Article  PubMed  CAS  Google Scholar 

  2. Ayuso E., Chillon M., Agudo J., Haurigot V., Bosch A., Carretero A., Otaegui P.J., Bosch F.: In vivo gene transfer to pancreatic beta cells by systemic delivery of adenoviral vectors. Hum. Gene Ther. 15:805–812, 2004

    Article  PubMed  CAS  Google Scholar 

  3. Shifrin A.L., Auricchio A., Yu Q.C., Wilson, J., Raper S.E.: Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemia. Gene Ther. 8:1480–1489, 2001

    Article  PubMed  CAS  Google Scholar 

  4. Sigalla J., David A., Anegon I., Fiche M., Huvelin J.M., Boeffard F., Cassard A., Soulillou J.P., Le Mauff B.: Adenovirus-mediated gene transfer into isolated mouse adult pancreatic islets: normal beta-cell function despite induction of an anti-adenovirus immune response. Hum. Gene Ther. 8:1625–1634, 1997

    PubMed  CAS  Google Scholar 

  5. McClane S.J., Chirmule N., Burke C.V., Raper S.E.: Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration. Hum. Gene Ther. 8:2207–2216, 1997

    PubMed  CAS  Google Scholar 

  6. Castaing M., Guerci A., Mallet J., Czernichow P., Ravassard P., Scharfmann R.: Efficient restricted gene expression in beta cells by lentivirus-mediated gene transfer into pancreatic stem/progenitor cells. Diabetologia 48:709–719, 2005

    Article  PubMed  CAS  Google Scholar 

  7. Kobinger G.P., Deng S., Louboutin J.P., Vatamaniuk M., Matschinsky F., Markmann J.F., Raper S.E., Wilson J.M.: Transduction of human islets with pseudotyped lentiviral vectors. Hum. Gene Ther. 15:211–219, 2004

    Article  PubMed  CAS  Google Scholar 

  8. Giannoukakis N., Mi Z., Gambotto A., Eramo A., Ricordi C., Trucco M., Robbins P.: Infection of intact human islets by a lentiviral vector. Gene Ther. 6:1545–1551, 1999

    Article  PubMed  CAS  Google Scholar 

  9. Gallichan W.S., Kafri T., Krahl T., Verma I.M., Sarvetnick N.: Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum. Gene Ther. 9:2717–2726: 1998

    PubMed  CAS  Google Scholar 

  10. Carter P.J., Samulski R.J.: Adeno-associated viral vectors as gene delivery vehicles. Int. J. Mol. Med. 6:17–27, 2000

    PubMed  CAS  Google Scholar 

  11. Grimm D., Kay M.A.; From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther. 3: 281–304, 2003

    Article  PubMed  CAS  Google Scholar 

  12. Flannery J.G., Zolotukhin S., Vaquero M.I., LaVail M.M., Muzyczka N., Hauswirth W.W.; Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94: 6916–6921, 1997

    Article  PubMed  CAS  Google Scholar 

  13. Song S., Morgan M., Ellis T., Poirier A., Chesnut K., Wang J., Brantly M., Muzyczka N., Byrne B.J., Atkinson M., Flotte T.R.; Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 95: 14384–14388, 1998

    Article  PubMed  CAS  Google Scholar 

  14. Zhang Y.C., Pileggi A., Agarwal A., Molano R.D., Powers M., Brusko T., Wasserfall C., Goudy K., Zahr E., Poggioli R., Scott-Jorgensen M., Campbell-Thompson M., Crawford J.M., Nick H., Flotte T., Ellis T.M., Ricordi C., Inverardi L., Atkinson M.A.; Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes 52: 708–716, 2003

    Article  PubMed  CAS  Google Scholar 

  15. Flotte T., Agarwal A., Wang J., Song S., Fenjves E.S., Inverardi L., Chesnut K., Afione S., Loiler S., Wasserfall C., Kapturczak M., Ellis T., Nick H., Atkinson M.: Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. Diabetes 50: 515–520, 2001

    Article  PubMed  CAS  Google Scholar 

  16. Kapturczak M., Zolotukhin S., Cross J., Pileggi A., Molano R.D., Jorgensen M., Byrne B., Flotte T.R., Ellis T., Inverardi L., Ricordi C., Nick H., Atkinson M., Agarwal A., Transduction of human and mouse pancreatic islet cells using a bicistronic recombinant adeno-associated viral vector. Mol. Ther. 5:154–160, 2002

    Article  PubMed  CAS  Google Scholar 

  17. Loiler S.A., Conlon T.J., Song S., Tang Q., Warrington K.H., Agarwal A., Kapturczak M., Li C., Ricordi C., Atkinson M.A., Muzyczka N., Flotte T.R.: Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Ther. 10: 1551–1558, 2003

    Article  PubMed  CAS  Google Scholar 

  18. Rehman K.K., Wang Z., Bottino R., Balamurugan A.N., Trucco M., Li J., Xiao X., Robbins P.D.: Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors. Gene Ther. 12:1313–1323, 2005

    Article  PubMed  CAS  Google Scholar 

  19. Wang A.Y., Peng P.D., Ehrhardt A., Storm T.A., Kay M.A.: Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo. Hum. Gene Ther. 15:405–413, 2004

    Article  PubMed  CAS  Google Scholar 

  20. Loiler S.A., Tang Q., Clarke T., Campbell-Thompson M.L., Chiodo V., Hauswirth W., Cruz P., Perret-Gentil M., Atkinson M.A., Ramiya V.K., Flotte T.R.: Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts. Mol. Ther. 12:519–527, 2005

    Article  PubMed  CAS  Google Scholar 

  21. Wang Z., Zhu T., Rehman K.K., Bertera S., Zhang J., Chen C., Papworth G., Watkins S., Trucco M., Robbins P.D., Li J., Xiao X.: Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes. Diabetes 55:875–884, 2006

    Article  PubMed  CAS  Google Scholar 

  22. Chang L.J., Zaiss A.K.: Lentiviral vectors. Prepartion and use. Method. Mol. Med. 69:303–318, 2002

    CAS  Google Scholar 

  23. Chen X.G., Zhu H.Z., Gong J.L., Li F., Xue J.L.: Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero. Acta Pharmacol. Sin. 25:789–793, 2004

    PubMed  CAS  Google Scholar 

  24. Follenzi A., Sabatino G., Lombardo A., Boccaccio C., Naldini L.: Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum. Gene Ther. 13:243–260, 2002

    Article  PubMed  CAS  Google Scholar 

  25. Nakai H., Fuess S., Storm T.A., Muramatsu S., Nara Y., Kay M.A.: Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J. Virol. 79:214–224, 2005

    Article  PubMed  CAS  Google Scholar 

  26. Wang Z., Zhu T., Qiao C., Zhou L., Wang B., Zhang J., Chen C., Li J., Xiao X.: Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23:321–328, 2005

    Article  PubMed  CAS  Google Scholar 

  27. Xiao X., Li J., Samulski R.J.: Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098–8108, 1996

    PubMed  CAS  Google Scholar 

  28. Sutherland R.M., McKenzie B.S., Zhan Y., Corbett A.J., Fox-Marsh A., Georgiou H.M., Harrison L.C., Lew A.M.: Anti-CD45RB antibody deters xenograft rejection by modulating T cell priming and homing. Int. Immunol. 14:953–962, 2002

    Article  PubMed  CAS  Google Scholar 

  29. Akache B., Grimm D., Pandey K., Yant S.R., Xu H., Kay M.A.: The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 80:9831–9836, 2006

    Article  PubMed  CAS  Google Scholar 

  30. Thomas C.E., Storm T.A., Huang Z., Kay M.A.: Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J. Virol. 78:3110–3122, 2004

    Article  PubMed  CAS  Google Scholar 

  31. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W. O’Malley KL, During M.J.: Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148–154, 1994

    Article  PubMed  CAS  Google Scholar 

  32. Snyder R.O., Miao C., Meuse L., Tubb J., Donahue B.A., Lin H.F., Stafford D.W., Patel S., Thompson A.R., Nichols T., Read M.S., Bellinger D.A., Brinkhous K.M., Kay M.A.: Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat. Med. 5:64–70, 1999

    Article  PubMed  CAS  Google Scholar 

  33. Mingozzi F., Schuttrumpf J., Arruda V.R., Liu Y., Liu Y.L. High K.A., Xiao W., Herzog R.W.: Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector. J. Virol. 76:10497–10502, 2002

    Article  PubMed  CAS  Google Scholar 

  34. Davidson B.L., Stein C.S., Heth J.A., Martins I., Kotin R.M., Derksen T.A., Zabner J., Ghodsi A., Chiorini J.A.: Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA 97:3428–3432, 2000

    Article  PubMed  CAS  Google Scholar 

  35. Zabner J., Seiler M., Walters R., Kotin R.M., Fulgeras W., Davidson B.L., Chiorini J.A.: Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74:3852–3858, 2000

    Article  PubMed  CAS  Google Scholar 

  36. Higashikawa F., Chang L.: Kinetic analyses of stability of simple and complex retroviral vectors. Virology 280:124–131, 2001

    Article  PubMed  CAS  Google Scholar 

  37. Chirmule N., Propert K., Magosin S., Qian Y., Qian R., Wilson J.: Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 6:1574–1583, 1999

    Article  PubMed  CAS  Google Scholar 

  38. Zhang Y.C., Powers M., Wasserfall C., Brusko T., Song S., Flotte T., Snyder R.O., Potter M., Scott-Jorgensen M., Campbell-Thompson M., Crawford J.M., Nick H.S., Agarwal A., Ellis T.M., Atkinson M.A.: Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Gene Ther. 11:233–240, 2004

    Article  PubMed  CAS  Google Scholar 

  39. Gao G.P., Alvira M.R., Wang L., Calcedo R., Johnston J., Wilson J.M.: Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99:11854–11859, 2002

    Article  PubMed  CAS  Google Scholar 

  40. Wang L., Calcedo R., Nichols T.C., Bellinger D.A., Dillow A., Verma I.M., Wilson J.M.: Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood 105:3079–3086, 2005

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work is in part supported by the American Heart Association grant ( 0435243N, National Institute of Health grant R01 HL067248, and a private donation from John Horst, Tampa, Florida.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y. Clare Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, H., Wolfe, S.H., Valencia, V. et al. Efficient and persistent transduction of exocrine and endocrine pancreas by adeno-associated virus type 8. J Biomed Sci 14, 585–594 (2007). https://doi.org/10.1007/s11373-007-9159-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11373-007-9159-1

Keywords

Navigation